Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial

BACKGROUND: The effect of enzalutamide on health-related quality of life (HRQoL) in the PREVAIL trial in chemotherapy-naïve men with metastatic castration-resistant prostate cancer was analyzed using the generic EQ-5D instrument. METHODS: Patients received oral enzalutamide 160 mg/day (n = 872) or p...

Descripción completa

Detalles Bibliográficos
Autores principales: Devlin, Nancy, Herdman, Michael, Pavesi, Marco, Phung, De, Naidoo, Shevani, Beer, Tomasz M., Tombal, Bertrand, Loriot, Yohann, Ivanescu, Cristina, Parli, Teresa, Balk, Mark, Holmstrom, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481866/
https://www.ncbi.nlm.nih.gov/pubmed/28645287
http://dx.doi.org/10.1186/s12955-017-0704-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481866/
https://www.ncbi.nlm.nih.gov/pubmed/28645287
http://dx.doi.org/10.1186/s12955-017-0704-y

Ejemplares similares